Category Archives: Actos

Featured Stories

Medtronic Infuse Lawsuit Alleges Off-Label Use Cause Painful Complications

A man in Louisiana has filed suit against Medtronic Inc. over injuries allegedly cause by off-label use of its Infuse Bone Graft product. The plaintiff, who received Infuse during transforaminal spinal lumbar fusion surgery, claims that the bone growth protein caused unwanted bone growth along his spine, worsening the back ...

Read More

Western Pennsylvania Familes File Suit Over Alleged Fracking Pollution

Three families in western Pennsylvania believe a leading hydraulic fracturing (fracking) company and two water testing labs are conspiring to produce false results that show natural gas drilling is not contaminating their private water wells.

Read More

Exposure to Common Pesticide May Increase ADHD Risk

Exposure to Common Pesticide May Increase ADHD Risk

A new study has found that exposure to a common household pesticide may increase the risk of attention deficit hyperactivity disorder (ADHD) in children.

Read More

Knee Replacement Patients Should Consider Nickel Allergies before Surgery

Individuals considering undergoing knee replacement surgery should ask their doctors to run a test to determine if they have a nickel allergy. Determining if a patient suffers from a nickel allergy will ensure the right knee implant is chosen for their surgery, and possibly save them from considerable pain and ...

Read More

Bronx Teenager Killed in Hit-and-Run, Second Teen Injured

A Port Jefferson Station man was killed on Wednesday in a single-vehicle crash on the Northern State Pkwy in Dix Hills west of Exit 42. He was driving a Nissan Altima.

Read More

Older Patients Face Heart Attack Risk Following Surgery

Older Hip Implant, Knee Replacement Patients Face Heart Attack Risk Following Surgery

An emerging report reveals that older hip implant and knee replacement patients face increased heart attack risks following surgery. The risk for acute myocardial infarction (AMI) was seen in the first two weeks after these surgical procedures.

Read More

Federal Judge Certifies Medtronic Infuse Shareholder Class Action Lawsuit

A shareholder lawsuit alleging Medtronic Inc. illegally promoted the off-label use of its Infuse bone growth product has been granted class action status by U.S. District Judge Paul Magnuson of Minnesota. According to a report from Law360.com, the Medtronic Infuse off-label promotion lawsuit was filed by several institutional investors on ...

Read More

Post -Tonsillectomy Morphine Life-Threatening in Children

Post -Tonsillectomy Morphine can be Life-Threatening in Children, Study Finds

A new study published in Pediatrics suggests that morphine can result in life-threatening respiratory problems when given to children after a tonsillectomy.

Read More

Johnson & Johnson Marketing of Gynecare Prolift Transvaginal Mesh Raises More Questions

Johnson & Johnson and its Ethicon unit are again coming under scrutiny for the way it marketed its Gynecare ProLift transvaginal mesh product. According to a new report from Bloomberg News, Johnson & Johnson continued marketing the Gynecare ProLift device for months after it received a warning from the ...

Read More

Study Finds Metal-on-Metal Hip Implants Associated with High Incidence of Pseudotumors

Yet another study is adding to concerns about the potential dangers associated with metal-on-metal hip implants. The study, published in the Journal of Bone and Joint Surgery, found that large diameter metal-on-metal total hip replacement may be associated with a substantially higher incidence of pseudotumor formation.

Read More

Federal Jury Awards $9 Billion in Damages in Actos Bladder Cancer Case

After deliberating for about four hours yesterday, a federal jury ordered Takeda Pharmaceuticals and Eli Lilly & Co. to pay a combined $9 billion in punitive damages to Terrence Allen, finding that the drug makers hid the bladder cancer risks … Continue reading

Posted in Actos, Health Concerns, Legal News, Pharmaceuticals |

Actos Jury Advised Takeda Officials Hid Cancer Risks

actos-hid-cancer-risk-jury-told

The federal trial that just started and involving Actos, Takeda Pharmaceutical Co.’s Type II diabetes drug, includes allegations that Takeda hid risks associated with Actos from physicians and consumers. The litigation accuses Takeda of hiding risks associated with Actos. Because … Continue reading

Posted in Actos, Pharmaceuticals |

First Bellwether Trial in Actos Multidistrict Litigation Underway

actos-litgation-begins

The first federal bellwether trial alleging that the diabetes drug Actos (pioglitazone) caused bladder cancer begins today. The trial is taking place in the U.S. District Court for the Western District of Louisiana before the Honorable Rebecca F. Doherty. The plaintiffs … Continue reading

Posted in Actos, Health Concerns, Legal News, Pharmaceuticals |

Jury Selection Completed in First Actos Bladder Cancer Bellwether Trial

actos-lawsuit-trial-jury-selection

Jury selection was completed on Monday, January 27 in the first bellwether case in the Actos bladder cancer litigation. After pretrial matters January 30, testimony will begin February 3, with the trial expected to last six weeks. This case was … Continue reading

Posted in Actos, Health Concerns, Legal News, Pharmaceuticals |

Actos Maker, Takeda, Hid Drug’s Risks from Patients, Doctors

takeda_hid_actos_risks

Another Actos lawsuit alleges that Takeda Pharmaceutical Co., the maker of the Type 2 diabetes drug, put profits before patient safety and “duped” patients. The lawsuit states that Takeda should be held liable in the cancer death of a former … Continue reading

Posted in Actos, Legal News, Pharmaceuticals |

Florida Man Alleges Serious Injuries After Taking Diabetes Drug, Actos

florida_actos_bladder_cancer

A Florida man alleges that he developed bladder cancer after taking the Type 2 diabetes drug, Actos (pioglitazone), for nearly seven years. A lawsuit has been filed on behalf of the man and is just one of thousands of lawsuits … Continue reading

Posted in Actos, Pharmaceuticals |

Lawsuit Accuses Actos Makers of Placing Profits Before Patient Safety

actos_profit_over_safety

A lawsuit alleges that Asia’s largest drug maker, Takeda Pharmaceuticals, put profits before patient safety. Actos (pioglitazone), Takeda’s Type 2 diabetes drug, has been at the center of thousands of personal injury lawsuits. Takeda officials were aware, as far back … Continue reading

Posted in Actos, Legal News, Pharmaceuticals |

Another Lawsuit Filed Over Allegations that Actos is Tied to Bladder Cancer

actos-lawsuit-oregon_cancer

Another lawsuit has been filed against the makers of the Type 2 diabetes drug, Actos, over allegations that the medication caused the Oregon man to develop bladder cancer. The lawsuit also alleges that the drug makers were aware of the … Continue reading

Posted in Actos, Legal News, Pharmaceuticals |

Another Actos User Alleges Bladder Cancer Caused by Type 2 Diabetes Drug

new_actos_bladder_cancer_claim

A Florida woman is alleging that taking the Type 2 diabetes drug, Actos (pioglitazone), caused her to develop bladder cancer, according to a lawsuit brought against the maker of the drug, Takeda Pharmaceuticals. The woman began taking Actos from about … Continue reading

Posted in Actos, Legal News, Pharmaceuticals |

Gum Disease Tied to Increased Diabetes Risk, May Lead to Increased Risks Tied to Some Type 2 Diabetes Drugs

gum_disease_linked_to_diseases

The links between dental disease and other diseases have been growing, for instance dental disease has been tied to increased risks for developing diabetes and heart disease; pregnancy complications; and, potentially, dementia. Type 2 diabetes is typically treated with any … Continue reading

Posted in Actos, Byetta Cancer, Pharmaceuticals |

© 2005-2018 Parker Waichman LLP ®. All Rights Reserved.